CareCloud removes Series B 8.75% preferred from Nasdaq
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
25-NSE
Rhea-AI Filing Summary
CareCloud, Inc. notified the removal of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock from listing and registration on the Nasdaq Stock Market LLC. Nasdaq certified it has complied with 17 CFR 240.12d2-2 and the issuer confirmed compliance with the Exchange's voluntary withdrawal requirements.
Key Figures
Commission File Number: 001-36529
Coupon: 8.75%
Issuer address: 7 Clyde Road, Somerset, NJ 08873
+2 more
5 metrics
Commission File Number
001-36529
Form 25 cover
Coupon
8.75%
Series B Cumulative Redeemable Perpetual Preferred Stock
Issuer address
7 Clyde Road, Somerset, NJ 08873
principal executive offices
Regulation cited
17 CFR 240.12d2-2
governing removal/withdrawal
Form expiration header
March 31, 2018
cover page expiration line
Key Terms
Form 25, 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, 17 CFR 240.12d2-2
3 terms
Form 25 regulatory
"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"
A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock financial
"8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Description of class of securities)"
17 CFR 240.12d2-2 regulatory
"Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules"
A U.S. Securities and Exchange Commission rule that describes the conditions and procedural steps for a security to be removed from public registration or reporting under the Securities Exchange Act of 1934. For investors, it matters because it explains when a company’s shares can stop being subject to regular disclosure and exchange listing rules — similar to knowing when a publicly tracked product will be discontinued and no longer send updates, which affects transparency and liquidity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What security did CareCloud (CCLD) remove from Nasdaq?
The filing states the 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock was removed from listing on Nasdaq. Nasdaq certified compliance with 17 CFR 240.12d2-2 and the issuer confirmed it followed the Exchange’s withdrawal procedures.
Who certified the removal on behalf of the exchange?
Nasdaq Stock Market LLC certified the removal and attested it had reasonable grounds to file Form 25. The certification was signed on behalf of Nasdaq by an authorized individual, identified in the filing as Katelin Rowe, CDO Analyst.
Does the Form 25 show CareCloud initiated or the exchange initiated the removal?
The filing records that Nasdaq complied with rules to strike the class from listing and that the issuer complied with the Exchange's requirements for voluntary withdrawal. Both Nasdaq and the issuer are described as having followed applicable procedures under 17 CFR 240.12d2-2.
What regulatory citation governs the removal in this filing?
The filing cites 17 CFR 240.12d2-2 (subsections (a)(1)–(a)(4) and (b)/(c)) as the regulatory basis for the listing strike and voluntary withdrawal. Those citations appear verbatim in the Form 25 notification excerpt.
Where are CareCloud’s principal executive offices listed in the filing?
The filing lists the issuer’s principal executive offices as 7 Clyde Road, Somerset, New Jersey 08873 with telephone number 732-873-5133. This address and contact are included on the Form 25 cover information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
